Interested in learning more about Hyfe? Read about all of our news, announcements and insights here!
Q & A with Dr. Marc Judson
Leading sarcoidosis expert is exploring cough monitoring in pulmonary sarcoidosis to assess treatment efficacy, anticipating that cough improvement precedes other symptom relief, revolutionizing patient care
Acoustic AI Frameworks: Single-Sound Analysis vs. Continuous Cough Monitoring
Review of single-sound analysis vs. continuous cough monitoring in AcousticAI diagnostics. Highlights the latter's edge in scalability, accuracy, and patient compliance for advancing respiratory health.
Q&A with Dr Dominic Sykes - The first clinical trial integrating continuous longitudinal cough data with esophageal manometry
Q&A session with Dr. Dominic Sykes, focusing on his pioneering clinical trial that integrates continuous longitudinal cough data with oesophageal manometry.
New Hyfe AI Study Validates the Accuracy of AI-Powered Cough Detection Human Annotators
Research demonstrates the accuracy of Hyfe’s automated cough monitoring process and is the first to observe differences in type and length of cough between men and women.
Hyfe Unveils Next-Generation CoughPro App: Advanced Tracking and Community Features Revolutionize Chronic Cough Management
AI company transitions app to subscription model and adds exclusive new features for users in the UK, Canada, Europe and global users outside the U.S.
Majority of Surveyed “Chronic Coughers” are 55+ and Cough Over 450 Times Per Day, Data from Hyfe AI Finds
Insights from over 4,000 consumer cough-tracking app users sheds light on those struggling with chronic cough and key characteristics of the condition that needs greater awareness and more treatment options
Imagine a World In Which Monitoring Cough Frequency can Predict and Prevent COPD Exacerbations
Cough is prevalent across diseases yet its tracking has been elusive, stalling scientific advancements. Hyfe's tech is changing this - we're now able to analyze objective cough data & predict risk.
Hyfe AI and ActiGraph Partner to Revolutionize Clinical Trials with AI-Powered Cough Detection
Hyfe's technology integrated into ActiGraph’s new FDA-cleared LEAP wearable device that will advance the use of remote patient monitoring in chronic cough clinical research.
Hyfe AI Announces New Remote Cough Monitoring Integration, Aiding to Reduce Patient Hospitalization and Improve Virtual Care
Studies show remote patient monitoring technology better predicts cough exacerbations to ultimately improve quality of life and reduce healthcare costs for patients with chronic cough.
Hyfe Announces Plans to Launch Digital Therapeutic for Chronic Coughers
Hyfe is expanding into chronic cough treatment with the world's first digital therapeutic for cough, using a proprietary model that combines real time cough frequency with cough suppression therapy.
Hyfe is Listed on CB Insights List of the Most Promising Digital Health Companies
150 winners selected out of 13,000 private companies; Hyfe recognized for contributions in screening, monitoring and diagnostics technologies